Health Law Review articles from September 2003

Health Law Review archives from September 2003

Spare embryos and stem cell research: consent issues.
September 22, 2003... Introduction Embryonic stem cells are touted as a source of promising treatment for debilitating diseases such as Parkinsons, Alzheimers, diabetes, cardiovascular disease, and many others. (1) In order to exploit the therapeutic potential...

Monitoring contracts with industry: why research ethics boards must be involved.
September 22, 2003... Introduction Industry-university collaboration is an increasingly common phenomenon in Canada. A recent study on university-industry partnerships in this country indicated that the amount of research funded by private companies jumped from...

Creating a patent clearinghouse in Canada: a solution to problems of equity and access.
September 22, 2003... Two of the most pressing normative questions surrounding biotechnology patenting today relate to the equitable distribution of the products of biotechnological research and ensuring fair access to those products. Often discussed under the...

Representations of cloning in the public sphere.
September 22, 2003... This poster was presented at the at Genome Canada G[E.sup.3]LS Winter Symposium in Montreal, February 6-8. 2003. Research Question What are the social representations of cloning risks and benefits? Methodology Focus groups: In...

Legal challenges to donor anonimity. (gamete donors)
September 22, 2003... Abstract Several legal principles challenge the current policy of gamete donor anonymity, and require that Canadian legislation clearly move toward a policy of open donor records. These considerations include provisions of the United...